<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35465342</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2532-1900</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>41</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology</Title>
          <ISOAbbreviation>Acta Myol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A novel compound heterozygous mutation in PYGM gene associated with McArdle's disease.</ArticleTitle>
        <Pagination>
          <StartPage>37</StartPage>
          <EndPage>40</EndPage>
          <MedlinePgn>37-40</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.36185/2532-1900-067</ELocationID>
        <Abstract>
          <AbstractText>McArdle's disease is an autosomal recessive glycogenosis due to mutation in the myophosphorylase gene (<i>PYGM</i>) resulting in a pure myopathy. The clinical onset typically occurs in childhood with cramps, myalgia, and intolerance to physical exercise, although late onset forms are also reported. We describe a case of a 17-year-old male complaining of cramps and myalgia following brief and intense exercise. The patient reported marked improvement in muscle fatigability few minutes after starting aerobic exercise. When he was a child, he had experienced few episodes of vomiting, nausea, and black colored urine following physical activity. Laboratory testings revealed high creatine kinase serum levels. Genetic testings for metabolic myopathies demonstrated a compound heterozygous for two <i>PYGM</i> mutations (p.R570Q and p.K754Nfs*49) allowing the diagnosis of McArdle's disease. To date, 183 mutations in the PYGM gene are listed in Human Gene Mutation Database Professional 2021.2, but this novel compound heterozygosis has never been reported before.</AbstractText>
          <CopyrightInformation>©2022 Gaetano Conte Academy - Mediterranean Society of Myology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Iacono</LastName>
            <ForeName>Salvatore</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Neurology, Department of Biomedicine, Neuroscience, and advanced Diagnostic (BiND), University of Palermo, Palermo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lupica</LastName>
            <ForeName>Antonino</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Neurology, Department of Biomedicine, Neuroscience, and advanced Diagnostic (BiND), University of Palermo, Palermo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Di Stefano</LastName>
            <ForeName>Vincenzo</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Neurology, Department of Biomedicine, Neuroscience, and advanced Diagnostic (BiND), University of Palermo, Palermo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Borgione</LastName>
            <ForeName>Eugenia</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Unit of Neuromuscular Diseases, Oasi Research Institute-IRCCS, Troina, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brighina</LastName>
            <ForeName>Filippo</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Neurology, Department of Biomedicine, Neuroscience, and advanced Diagnostic (BiND), University of Palermo, Palermo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>31</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Acta Myol</MedlineTA>
        <NlmUniqueID>9811169</NlmUniqueID>
        <ISSNLinking>1128-2460</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 2.4.1.-</RegistryNumber>
          <NameOfSubstance UI="D024982">Glycogen Phosphorylase, Muscle Form</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024982" MajorTopicYN="Y">Glycogen Phosphorylase, Muscle Form</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006012" MajorTopicYN="Y">Glycogen Storage Disease Type V</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009120" MajorTopicYN="N">Muscle Cramp</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063806" MajorTopicYN="N">Myalgia</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">McArdle’s disease</Keyword>
        <Keyword MajorTopicYN="N">PYGM</Keyword>
        <Keyword MajorTopicYN="N">glycogenosis</Keyword>
        <Keyword MajorTopicYN="N">hyperCKemia</Keyword>
        <Keyword MajorTopicYN="N">second wind phenomenon</Keyword>
      </KeywordList>
      <CoiStatement>Conflict of interest statement The Authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>25</Day>
          <Hour>5</Hour>
          <Minute>49</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35465342</ArticleId>
        <ArticleId IdType="pmc">PMC9004334</ArticleId>
        <ArticleId IdType="doi">10.36185/2532-1900-067</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Quinlivan R, Buckley J, James M, et al. . McArdle disease: a clinical review. J Neurol Neurosurg Psychiatry
2010;81:1182-1188. https://doi.org/10.1136/JNNP.2009.195040
10.1136/JNNP.2009.195040</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/JNNP.2009.195040</ArticleId>
            <ArticleId IdType="pubmed">20861058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Llavero F, Sastre AA, Montoro ML, et al. . Mcardle disease: new insights into its underlying molecular mechanisms. Int J Mol Sci
2019;20. https://doi.org/10.3390/ijms20235919
10.3390/ijms20235919</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms20235919</ArticleId>
            <ArticleId IdType="pmc">PMC6929006</ArticleId>
            <ArticleId IdType="pubmed">31775340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aquaron R, Bergé-Lefranc J louis, Pellissier JF, et al. . Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation. Neuromuscul Disord
2007;17:235-241. https://doi.org/10.1016/j.nmd.2006.12.014
10.1016/j.nmd.2006.12.014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nmd.2006.12.014</ArticleId>
            <ArticleId IdType="pubmed">17324573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martín MA, Rubio JC, Buchbinder J, et al. . Molecular heterogeneity of myophosphorylase deficiency (Mcardle’s disease): a genotype-phenotype correlation study. Ann Neurol
2001;50:574-581. https://doi.org/10.1002/ANA.1225
10.1002/ANA.1225</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ANA.1225</ArticleId>
            <ArticleId IdType="pubmed">11706962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nogales-Gadea G, Brull A, Santalla A, et al. . McArdle disease: update of reported mutations and polymorphisms in the PYGM Gene. Hum Mutat
2015;36:669-678. https://doi.org/10.1002/humu.22806
10.1002/humu.22806</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/humu.22806</ArticleId>
            <ArticleId IdType="pubmed">25914343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santalla A, Nogales-Gadea G, Encinar AB, et al. . Genotypic and phenotypic features of all Spanish patients with McArdle disease: a 2016 update. BMC Genomics
2017;18(Suppl 8). https://doi.org/10.1186/s12864-017-4188-2
10.1186/s12864-017-4188-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12864-017-4188-2</ArticleId>
            <ArticleId IdType="pmc">PMC5688471</ArticleId>
            <ArticleId IdType="pubmed">29143597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vissing J, Duno M, Schwartz M, et al. . Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease. Brain
2009;132:1545-1552. https://doi.org/10.1093/BRAIN/AWP065
10.1093/BRAIN/AWP065</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/BRAIN/AWP065</ArticleId>
            <ArticleId IdType="pubmed">19433441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haller H, Vissing J. Spontaneous “second wind” and glucose-induced second “second wind” in McArdle disease: oxidative mechanisms. Arch Neurol
2002;59:1395-1402. https://doi.org/10.1001/ARCHNEUR.59.9.1395
10.1001/ARCHNEUR.59.9.1395</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/ARCHNEUR.59.9.1395</ArticleId>
            <ArticleId IdType="pubmed">12223025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lupica A, Di Stefano V, Gagliardo A, et al. . Inherited neuromuscular disorders: which role for serum biomarkers?
Brain Sci
2021;11. https://doi.org/10.3390/BRAINSCI11030398
10.3390/BRAINSCI11030398</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/BRAINSCI11030398</ArticleId>
            <ArticleId IdType="pmc">PMC8004068</ArticleId>
            <ArticleId IdType="pubmed">33801069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lucia A, Nogales-Gadea G, Pérez M, et al. . McArdle disease: what do neurologists need to know?
Nat Clin Pract Neurol
2008;4:568-577. https://doi.org/10.1038/ncpneuro0913
10.1038/ncpneuro0913</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncpneuro0913</ArticleId>
            <ArticleId IdType="pubmed">18833216</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
